EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Huntington's Disease and Huntington's Disease‐like 2 ( HDL2 ) in Martinique

Ignacio Antolin-Sanfeliz iD, Anna-Gaelle Giguet-Valard iD, Sophie Duclos, Cécile Cazeneuve iD, Chloé Angelini iD, Aïssatou Signaté iD, Russell L Margolis iD, Cyril Goizet iD, Rémi Bellance iD

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.70379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Ignacio Antolin-Sanfeliz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Référence Caribéen des Maladies Neuromusculaires Rares, CHU de Martinique, Fort-de-France, France. Hauptthemen laut MEDLINE: Huntington Disease, Chorea. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Huntington's Disease‐like 2 (HDL2), caused by a CAG repeat expansion in JPH3 , closely resembles HD. All reported HDL2 patients to date have some African ancestry. While both disorders exist in the Caribbean, their relative frequency and clinical characteristics remain largely unknown.

Objectives

To characterize HD and HDL2 patients in Martinique.

Methods

We retrospectively analyzed all HD and HDL2 patients evaluated over 20 years at a single neurology center in Martinique, collecting longitudinal clinical features, UHDRS scores, and repeat lengths.

Results

In Martinique, combined HD and HDL2 minimum prevalence was 7.77/100,000. We ascertained 24 HD individuals, from 16 pedigrees, and 18 HDL2 individuals, from two pedigrees, one being the most extensive HDL2 pedigree yet reported. Because most HDL2 patients belong to a single large pedigree, the data must be interpreted with caution as familial clustering may introduce bias. HDL2 cases were predominantly male (83% vs. 45% in HD). Motor symptoms were the most frequent initial manifestation in both. Repeat length negatively correlated with estimated onset age in both diseases. Longitudinal motor (UHDRS‐TMS) and functional capacity (UHDRS‐TFC) scores in HDL2 revealed progressive worsening similar to HD. Inter‐ and intra‐familial clinical and genetic heterogeneity was obvious in both diseases. Anticipation was not exclusively reserved to paternal transmissions in HDL2.

Conclusions

HDL2 is nearly as prevalent as HD in Martinique. The study reinforces the similarities between HD and HDL2 in genotype–phenotype correlation and disease course, while highlighting heterogeneity and germline instability in HDL2. Interpretation is limited by the small number of HDL2 families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseChoreaHumansMaleFemaleMiddle AgedAdultMartiniqueRetrospective StudiesAgedPedigreeTrinucleotide Repeat ExpansionCognition DisordersDementiaHeredodegenerative Disorders, Nervous System

Stichwörter der Autor:innen

Huntington's disease (HD)Huntington's disease type 2 (HDL2)clinical characterizationepidemiologyneurodegenerative disorders

Autor:innen und Institutionen

  • Centre de Référence Caribéen des Maladies Neuromusculaires Rares, CHU de Martinique, Fort-de-France, France.
  • UF de Neurogénétique Moléculaire et Cellulaire, Département de Génétique, Hôpitaux Universitaires Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Centre de Référence Maladies Rares "Maladie De Huntington Et Autres Chorées" and Centre de référence maladies rares "Neurogénétique", Service de Génétique Médicale, Bordeaux University Hospital (CHU Bordeaux) and Univ.…
  • Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, and Department of Neurology, John Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Ignacio Antolin-Sanfeliz, Anna-Gaelle Giguet-Valard, Cécile Cazeneuve, Chloé Angelini, Aïssatou Signaté, Russell L Margolis, Cyril Goizet, Rémi Bellance

Zitieren

APA

Antolin-Sanfeliz, I., Giguet-Valard, A. G., Duclos, S., Cazeneuve, C., Angelini, C., Signaté, A., Margolis, R. L., Goizet, C., & Bellance, R. (2025). Huntington's Disease and Huntington's Disease‐like 2 ( HDL2 ) in Martinique. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70379

Vancouver

Antolin-Sanfeliz I, Giguet-Valard AG, Duclos S, Cazeneuve C, Angelini C, Signaté A, et al. Huntington's Disease and Huntington's Disease‐like 2 ( HDL2 ) in Martinique. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70379

BibTeX
@article{AntolinSanfeliz2025,
  author = {Antolin-Sanfeliz, Ignacio and Giguet-Valard, Anna-Gaelle and Duclos, Sophie and Cazeneuve, Cécile and Angelini, Chloé and Signaté, Aïssatou and Margolis, Russell L and Goizet, Cyril and Bellance, Rémi},
  title = {Huntington's Disease and Huntington's Disease‐like 2 ( HDL2 ) in Martinique},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.70379}
}
Kostenlos starten →